Papers5035209

Burch Retropubic Urethropexy Compared With Midurethral Sling With Concurrent Sacrocolpopexy: A Randomized Controlled Trial

Obstetrics and gynecology · 01-10-2016 · 5035209 on PMC →
22 citations FWCI 2.89 Pelvic floor disorders treatments Trend
Citation data as of 2026-04-12 (OpenAlex).
Entities in this paper
Retropubic midurethral sling Pelvic organ prolapse/stress urinary incontinence surgical mesh Urinary Incontinence Overall continence Stress-specific continence Patient Satisfaction Resolution of myocardial ischemia Serious adverse events and surgical complications

Extracted findings (5)

No difference was found in overall continence between the midurethral sling and Burch urethropexy groups at 6-month follow-up when performed concurrently with sacrocolpopexy (51% sling vs 41% Burch, p

Effect: null; OR 1.49; CI: 95% CI 0.71-3.13

Size: OR 1.49 CI: 95% CI 0.71-3.13

No statistically significant difference was found in stress-specific continence rates between the midurethral sling and Burch groups at 6 months (74% sling vs 57% Burch, p=0.06), though the direction

Effect: null; OR 2.10; CI: 95% CI 0.95-4.64

Size: OR 2.10 CI: 95% CI 0.95-4.64

Women who had a midurethral sling were significantly more likely to report satisfaction (78% vs 57%, p=0.04) and to rate their surgery as very successful for SUI (71% vs 50%, p=0.04) compared to Burch

Effect: improvement; 78% vs 57%

Size: 78% vs 57%

Women who had a midurethral sling were significantly more likely to have resolution of preexisting urgency incontinence at 6 months than women who had a Burch procedure (72% vs 41%, p=0.03).

Effect: improvement; 72% vs 41%

Size: 72% vs 41%

No difference was found in the rate of serious adverse events between groups (9% Burch vs 11% sling, p=0.77), with most events related to the laparotomy rather than the anti-incontinence procedure. No

Effect: null; 9% vs 11%

Size: 9% vs 11%